Vascular Adaptations in Pregnancy: The Critical Role of Endothelial Function and Nitric Oxide in Maternal-Fetal Health
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/046Keywords:
Vascular Endothelial Growth Factors , Nitric Oxide, Endothelin-1, Brachial Artery, Hypertension, Pregnancy-Induced Hypertension, PreeclampsiaAbstract
Background: Endothelial dysfunction is a critical factor in hypertensive disorders of pregnancy, such as preeclampsia. This study aimed to evaluate the role of endothelial function, nitric oxide (NO), and endothelin-1 (ET-1) in normotensive and hypertensive pregnancies to understand the underlying vascular adaptations.
Methods: A cross-sectional study was conducted at LUMHS, Jamshoro, from October 2023 to June 2024. A total of 120 pregnant women were divided into normotensive (n=60) and hypertensive (n=60) groups. Participants included pregnant women aged 18 to 40 years with singleton pregnancies between 20 and 36 weeks of gestation. Participants were recruited using a purposive sampling technique from the Obstetrics and Gynecology Department. Serum NO and ET-1 levels were measured, and endothelial function was assessed using flow-mediated dilation (FMD). Data analysis using SPSS 26.0 involved descriptive statistics, independent t-tests for NO and FMD comparisons, chi-square tests for categorical variables, and multivariate regression to adjust for confounders such as maternal age, BMI, and gestational age.
Results: Hypertensive women had lower NO levels (24.98 ± 4.72 vs. 34.23 ± 4.54 µmol/L) and FMD values (6.09 ± 1.55% vs. 10.14 ± 1.49%), and higher ET-1 levels (4.46 ± 0.72 vs. 2.52 ± 0.48 pg/mL) than normotensive women (all p < 0.0001). NO correlated positively with FMD (r = 0.61), while ET-1 correlated negatively with NO (r = -0.55) and FMD (r = -0.69). Multiple regression identified NO and ET-1 as significant FMD predictors.
Conclusion: Endothelial dysfunction in hypertensive pregnancies is characterized by reduced NO levels, elevated ET-1 levels, and impaired FMD.
References
Conrad KP. Emerging role of nitric oxide in regulation of vascular function during pregnancy. Am J Physiol Renal Physiol. 2011;300(2):F251–F262. doi:10.1152/ajprenal.00750.2010
Chun S, Malek AM, Braams R, et al. Nitric oxide and pregnancy: NO synthesis and signaling pathways in vascular adaptation. Physiology (Bethesda). 2020;35(4):260–269. doi:10.1152/physiol.00008.2020
Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda). 2009;24(2):58–71. doi:10.1152/physiol.00033.2008
Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 2018;9:973. doi:10.3389/fphys.2018.00973
Rennie MY, Whiteley KJ, Lysiak JJ, et al. Role of nitric oxide in vascular adaptation during pregnancy. Reprod Sci. 2021;28(1):12–21. doi:10.1007/s43032-020-00245-0
Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016;11(6):1102–1113. doi:10.2215/CJN.12081115
Lu F, Longo M, Tamayo E, et al. The effect of overexpression of endothelial nitric oxide synthase on placental angiogenesis in a mouse model. Am J Physiol Heart Circ Physiol. 2007;293(6):H3036–H3044. doi:10.1152/ajpheart.00677.2007
Mannaerts D, Faes E, Cos P, et al. Endothelial dysfunction in preeclampsia: the role of high-density lipoproteins. J Hypertens. 2018;36(6):1170–1180. doi:10.1097/HJH.0000000000001656
Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30(1–2):260–279. doi:10.3109/07420528.2012.719965
Banek CT, Bauer AJ, Gingery A, et al. Endothelial NO synthase uncoupling in placentas from women with preeclampsia. Hypertension. 2012;60(5):1268–1275. doi:10.1161/HYPERTENSIONAHA.112.198853
Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83. doi:10.1016/j.preghy.2012.01.001
Amaral LM, Cornelius DC, Harmon A, et al. Hypertension in pregnancy: a major risk factor for maternal and fetal morbidity and mortality. Am J Hypertens. 2015;28(2):147–158. doi:10.1093/ajh/hpu190
Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020;318(6):F1315–F1326. doi:10.1152/ajprenal.00016.2020
Spradley FT. Metabolic abnormalities and obesity’s impact on preeclampsia pathogenesis. Am J Physiol Regul Integr Comp Physiol. 2017;312(1):R5–R12. doi:10.1152/ajpregu.00336.2016
Khalil A, Cooper D, Harrington K. Pulse wave analysis: a preliminary study of a novel technique for the prediction of preeclampsia. BJOG. 2009;116(2):268–276. doi:10.1111/j.1471-0528.2008.01949.x
Staff AC, Redman CW, Williams D, et al. Pregnancy and long-term maternal cardiovascular health: progress through harmonization and consortium research. Hypertension. 2016;67(2):251–260. doi:10.1161/HYPERTENSIONAHA.115.06767
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683. doi:10.1056/NEJMoa031884
George EM, Granger JP. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens. 2011;24(9):964–969. doi:10.1038/ajh.2011.132
Shah DM. The role of RAS in the pathogenesis of preeclampsia. Curr Hypertens Rep. 2006;8(2):144–152. doi:10.1007/s11906-006-0004-8
Gupta S, Agarwal A, Banerjee J, et al. Oxidative stress and its role in female infertility and assisted reproduction: clinical implications. Reprod Biomed Online. 2007;11(5):641–650. doi:10.1016/S1472-6483(10)60679-1
Sgambati E, Marini M, Zappolini A, et al. Vascular endothelial growth factor expression in the placentas of pregnancies complicated by hypertension. J Clin Pathol. 2004;57(5):470–475. doi:10.1136/jcp.2003.013433
Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975. doi:10.1161/HYPERTENSIONAHA.107.107607
Lu X, Wang L, Lin C, et al. Endothelin-1 and endothelial dysfunction in pregnancy-induced hypertension. J Hum Hypertens. 2020;34(5):351–357. doi:10.1038/s41371-019-0278-6
Brownfoot FC, Tong S, Hannan NJ, et al. Endothelin and endothelin antagonists in preeclampsia. Clin Sci (Lond). 2017;131(6):441–448. doi:10.1042/CS20160778
Ahmed A, Ramma W. Unravelling the theories of preeclampsia: are the protective pathways the new paradigm? Br J Pharmacol. 2015;172(6):1574–1586. doi:10.1111/bph.12966
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
